Renal Denervation: 60 Second Insights
Published: 22 March 2019
-
Views:
5233
-
Likes:
7
-
Views:
5233
-
Likes:
7
-
Up Next -
26sPart 13 | Session 5 Ajay Kirtane
-
28sPart 13 | Session 6 Robert Schwartz
-
48sPart 1 | Session 1 Justin Davies Justin E Davies
-
40sPart 1 | Session 2 Aloke Finn Aloke V Finn
-
48sPart 1 | Session 3 David Kandzari
-
46sPart 1 | Session 4 Horst Sievert Horst Sievert
-
35sPart 1 | Session 5 Ajay Kirtane Ajay J Kirtane
-
41sPart 1 | Session 6 Robert Schwartz Robert S Schwartz
-
40sPart 2 | Session 1 Justin Davies Justin E Davies
-
38sPart 2 | Session 2 David Kandzari
-
17sPart 2 | Session 3 Horst Sievert Horst Sievert
-
33sPart 2 | Session 4 Ajay Kirtane Ajay J Kirtane
-
41sPart 2 | Session 5 Robert Schwartz Robert S Schwartz
-
55sPart 2 | Session 6 Patrick Serruys Patrick W Serruys
-
55sPart 2 | Session 7 Gerald Werner Gerald S Werner
-
25sPart 2 | Session 8 Aloke Finn Aloke V Finn
-
30sPart 3 | Session 1 Justin Davies Justin E Davies
-
35sPart 3 | Session 2 Aloke Finn Aloke V Finn
-
46sPart 3 | Session 3 David Kandzari
-
22sPart 3 | Session 4 Horst Sievert Horst Sievert
-
32sPart 3 | Session 5 Ajay Kirtane Ajay J Kirtane
-
42sPart 3 | Session 6 Robert Schwartz Robert S Schwartz
-
47sPart 4 | Session 1 Justin Davies Justin E Davies
-
22sPart 4 | Session 2 Aloke Finn Aloke V Finn
-
58sPart 4 | Session 3 David Kandzari
-
15sPart 4 | Session 4 Horst Sievert Horst Sievert
-
34sPart 4 | Session 5 Ajay Kirtane Ajay J Kirtane
-
33sPart 4 | Session 6 Robert Schwartz Robert S Schwartz
-
45sPart 5 | Session 1 Justin Davies Justin E Davies
-
24sPart 5 | Session 2 Aloke Finn Aloke V Finn
-
41sPart 5 | Session 3 David Kandzari
-
27sPart 5 | Session 4 Horst Sievert Horst Sievert
-
32sPart 5 | Session 5 Ajay Kirtane Ajay J Kirtane
-
42sPart 5 | Session 6 Robert Schwartz Robert S Schwartz
-
47sPart 5 | Session 7 Gerald Werner Gerald S Werner
-
36sPart 6 | Session 1 Justin Davies Justin E Davies
-
26sPart 6 | Session 2 Aloke Finn Aloke V Finn
-
51sPart 6 | Session 3 David Kandzari
-
30sPart 6 | Session 4 Horst Sievert Horst Sievert
-
39sPart 6 | Session 5 Ajay Kirtane Ajay J Kirtane
-
1m 1sPart 6 | Session 6 Robert Schwartz Robert S Schwartz
-
1m 7sPart 6 | Session 7 Gerald Werner Gerald S Werner
-
29sPart 7 Justin Davies Justin E Davies
-
23sPart 8 Justin Davies Justin E Davies
-
32sPart 9 | Session 1 Justin Davies Justin E Davies
-
1m 8sPart 9 | Session 2 David Kandzari
-
1m 12sPart 10 | Session 1 Justin Davies Justin E Davies
-
1m 18sPart 10 | Session 2 David Kandzari
-
54sPart 11 | Session 1 Justin Davies Justin E Davies
-
27sPart 11 | Session 2 Aloke Finn Aloke V Finn
-
54sPart 11 | Session 3 David Kandzari
-
29sPart 11 | Session 4 Horst Sievert Horst Sievert
-
33sPart 11 | Session 5 Ajay Kirtane Ajay J Kirtane
-
1m 1sPart 11 | Session 6 Robert Schwartz Robert S Schwartz
-
27sPart 12 | Session 1 Justin Davies Justin E Davies
-
31sPart 12 | Session 2 Aloke Finn Aloke V Finn
-
26sPart 12 | Session 3 David Kandzari
-
26sPart 12 | Session 4 Horst Sievert Horst Sievert
-
31sPart 12 | Session 5 Ajay Kirtane Ajay J Kirtane
-
49sPart 12 | Session 6 Robert Schwartz Robert S Schwartz
-
25sPart 13 | Session 1 Justin Davies Justin E Davies
-
21sPart 13 | Session 2 Aloke Finn Aloke V Finn
-
56sPart 13 | Session 3 David Kandzari
Overview
A short series of 60-second insight videos on renal denervation. Hear the expert views in under one minute!
More from this programme
Part 1
Thinking about patient preference, what role does RDN have in blood pressure control?
Part 2
What role do you see for renal denervation in control of blood pressure in your patients?
Part 3
Where does renal denervation fit in your current clinical practice?
Part 4
What are the biggest barriers to blood pressure control in your patients?
Part 5
Which patient groups are most receptive to RDN?
Part 6
What is needed to get widespread adoption into clinical practice?
Part 7
How have SPYRAL HTN-OFF and SPYRAL HTN-ON studies influenced your clinical practice?
| 1 session | |
| Justin Davies | Watch now |
Part 8
Thinking about the SPYRAL HTN-OFF and SPYRAL HTN-ON studies, what are the take-home messages for you?
| 1 session | |
| Justin Davies | Watch now |
Part 9
Thinking about the SPYRAL HTN-OFF and SPYRAL HTN-ON studies, for you, what are the key results?
| 2 sessions | |
| Justin Davies | Watch now |
| David Kandzari | Watch now |
Part 10
Can you give an overview of the RDN SPYRAL clinical trial program?
| 2 sessions | |
| Justin Davies | Watch now |
| David Kandzari | Watch now |
Part 11
Thinking about compliance, what are the advantages of RDN over pharmacological therapy?
Part 12
How does renal denervation work?
Part 13
Does renal denervation work?
Faculty Biographies
Horst Sievert
Director
Dr Horst Sievert, MD, is the Director of the CardioVascular Center Frankfurt, Sankt Katharinen, and the Department of Internal Medicine, Cardiology, and Vascular Medicine of the Sankt Katharinen Hospital in Frankfurt, Germany.
Dr Sievert is also an Associate Professor of Internal Medicine/Cardiology at the University of Frankfurt. Dr Sievert became Director of the Department of Interventional Cardiology and Angiology of the Heart Center Rotenburg in 1990, Senior Consultant at the Bethanien Hospital in Frankfurt in 1993, and Director of the CardioVascular Center Frankfurt, Sankt Katharinen in 2003. He has been the principal investigator in a number of clinical trials and has authored more than 130 manuscripts and 500 abstracts in peer-reviewed journals and 50 books and book contributions.